diabetes

You have accessRestricted Access
Calamari, Hyperkalemia, and Renin-Angiotensin System Blockade
Emily Janak and Holly Kramer

CJASN August 2022, 17 (8) 1116-1118; DOI: https://doi.org/10.2215/CJN.07280622

Add to Selected Citations
Open Access
Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection
Hiddo J.L. Heerspink, Remo H.M. Furtado, Otavio Berwanger, Gary G. Koch, Felipe Martinez, Omar Mukhtar, Subodh Verma, Samvel B. Gasparyan, Fengming Tang, Sheryl L. Windsor, Vicente Cés de Souza-Dantas, Mildren del Sueldo, Robert Frankel, Ali Javaheri, Rafael A. Maldonado, Caryn Morse, Marco Mota-Gomes, Douglas Shemin, Osvaldo Lourenço Silva, Alexandre Pereira Tognon, Marcel Twahirwa, Joan Buenconsejo, Russell Esterline, Jan Oscarsson, Philip Ambery, Anna Maria Langkilde and Mikhail N. Kosiborod

CJASN May 2022, 17 (5) 643-654; DOI: https://doi.org/10.2215/CJN.14231021

Add to Selected Citations
Open Access
Post-Transplant Cardiovascular Disease
Kelly A. Birdwell and Meyeon Park

CJASN December 2021, 16 (12) 1878-1889; DOI: https://doi.org/10.2215/CJN.00520121

Add to Selected Citations
Open Access
Kidney Effects of Empagliflozin in People with Type 1 Diabetes
David Z.I. Cherney, Petter Bjornstad, Bruce A. Perkins, Julio Rosenstock, Dietmar Neubacher, Jan Marquard and Nima Soleymanlou

CJASN November 2021, 16 (11) 1715-1719; DOI: https://doi.org/10.2215/CJN.07700621

Add to Selected Citations
You have accessRestricted Access
Transforming the Care of Patients with Diabetic Kidney Disease
Frank C. Brosius, David Cherney, Patrick O. Gee, Raymond C. Harris, Alan S. Kliger, Katherine R. Tuttle and Susan E. Quaggin; on behalf of the DKD-Collaborative ASN Taskforce

CJASN October 2021, 16 (10) 1590-1600; DOI: https://doi.org/10.2215/CJN.18641120

Add to Selected Citations
Open Access
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER)
Rajiv Agarwal, Patrick Rossignol, Martha R. Mayo, Ansgar Conrad, Susan Arthur, Bryan Williams and William B. White

CJASN September 2021, 16 (9) 1407-1409; DOI: https://doi.org/10.2215/CJN.02890221

Add to Selected Citations
Open Access
The Patient Voice in Health Care Decision Making
Tami Sadusky and Clint Hurst

CJASN July 2021, 16 (7) 991-992; DOI: https://doi.org/10.2215/CJN.18191120

Add to Selected Citations
You have accessRestricted Access
Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome
Kamyar Kalantar-Zadeh, Gregory G. Schwartz, Stephen J. Nicholls, Kevin A. Buhr, Henry N. Ginsberg, Jan O. Johansson, Ewelina Kulikowski, Kenneth Lebioda, Peter P. Toth, Norman Wong, Michael Sweeney, Kausik K. Ray and on behalf of the BETonMACE Investigators

CJASN May 2021, 16 (5) 705-716; DOI: https://doi.org/10.2215/CJN.16751020

Add to Selected Citations
You have accessRestricted Access
SGLT2 Inhibitors in Diabetic Kidney Disease
Sophia Zoungas and Ian H. de Boer

CJASN April 2021, 16 (4) 631-633; DOI: https://doi.org/10.2215/CJN.18881220

Add to Selected Citations
You have accessRestricted Access
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria
Meg Jardine, Zien Zhou, Hiddo J. Lambers Heerspink, Carinna Hockham, Qiang Li, Rajiv Agarwal, George L. Bakris, Christopher P. Cannon, David M. Charytan, Tom Greene, Adeera Levin, Jing-Wei Li, Brendon L. Neuen, Bruce Neal, Richard Oh, Megumi Oshima, Carol Pollock, David C. Wheeler, Dick de Zeeuw, Hong Zhang, Bernard Zinman, Kenneth W. Mahaffey and Vlado Perkovic

CJASN March 2021, 16 (3) 384-395; DOI: https://doi.org/10.2215/CJN.15260920

Add to Selected Citations

Main menu

User menu

Search

diabetes

Pages

Articles

Information for Authors

About

Journal Information

More Information